doc.ai

doc.ai

Created using Figma
Doc.ai is a conversational AI-powered platform for on-demand, quantified biology. This advanced natural language dialog system was designed for vertical medical domains, and can generate and communicate insights on genomic and pharmacogenomic, exposomic and anatomical data as well as sensor-based wellness features and hematology. With the help of this technology layer they are launching NEURON, a decentralized artificial intelligence platform which allows anyone to connect to the network and train their own AI, by pushing deep learning to edge devices (smartphones).
Sep 28, 2017
Oct 12, 2017
100% completed
$11 158 215
cap
goal
37% goal completed
Goal 30 000 000.00 USD
Cap 86 000 000.00 USD
past
  • 1 NRN
    =
    0.1 USD
Token Details
Ticker
NRN
Accepted Currencies
ETH, BTC
Company Details
Registered Country
United States
Additional Details
Categories
Platform, Cryptocurrency, Other

About doc.ai

With the help of this technology layer we are launching NEURON, a decentralized artificial intelligence platform which allows anyone to connect to the network and train their own AI, by pushing deep learning to edge devices (smartphones).

The Neuron (NRN) tokens give access to the AI network and reward the users (individuals or when the unite they become research organizations) who train their AI with tokens. With these tokens they can broadcast a competition on NEURON and create a bounty (prize) for data scientists. When these succeed in building a prediction model that provides unique insights into the proposed personal quantified biology profile, they win the prize.

The convergent collection of health data, the subsequent classification and the prediction models can be the first step to a documented preventive way of life where health is no longer a discrete but becomes a continuous function and the medical information chain shifts from a seller’s to a buyer’s market.

Features

Implementation of natural language processing for quantified biology, through decentralized AI and distributed edge learning on personal devices.

doc.ai Roadmap

  • Q3 2017

  • Initial stage of research.
  • Q3 - Q4 2017

  • Stage 1 - Development.
  • Q4 2017

  • Stage 2 - Deploy a test network and run tests.
  • Q4 2017

  • Stage 3 - Launch the main network.
  • Read More
  • Q1 2018

  • Initial stage of research.
  • Q1-Q2 2018

  • Stage 1 — Development.
  • Q2-Q3 2018

  • Stage 2 — Deploy a test network and run tests.
  • Q4 2018

  • Stage 3 — Launch the main network and run tests.

doc.ai Team

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Walter De Brouwer
CEO
unverified
Sam De Brouwer
COO
unverified
Anthea Chung
CFO
unverified
Jonathan Smith
CTO
unverified
Jeremy Howard
unverified
Alan Greene
unverified
Ryan Selkis
unverified

Advisors

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Udi Manber
Advisor
unverified

4 ICO

$43 388 296

Brad Mills
Advisor
unverified

doc.ai Last News

N/A
5.0 7
WEB2 Profile Vision Activity Potential Product Team

doc.ai Reviews

bitcoinexchangeguide.com
News, reviews

Doc.ai is a SaaS company that’s introducing blockchain technology to the medical community. The Palo Alto-based company is introducing three blockchain-based solutions over the next 12 months. These solutions involve medical robots that can communicate with patients using natural language. It’s the first step towards creating robot doctors. The various Doc.ai products help patients gain further insights into their medical status and the context of their lab results.

The Doc.ai crowdsale is taking place throughout September and October.

Read More
  • Due to potential time differences in information updates, please verify the accuracy of each ICO project through its official website or other official communication channels.
  • This information is not intended as a recommendation or suggestion for ICO investment. Please conduct thorough research on the relevant information and make your own informed decision regarding ICO participation.
  • If you identify any issues or errors in this content, or if you wish to submit your own ICO project for listing, please contact us via email at info@icoholder.com.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.